Final Report of a Trial of Intensive versus Standard Blood-Pressure Control
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In a previously reported randomized trial of standard and intensive systolic blood-pressure control, data on some outcome events had yet to be adjudicated and post-trial follow-up data had not yet been collected. METHODS: We randomly assigned 9361 participants who were at increased risk for cardiovascular disease but did not have diabetes or previous stroke to adhere to an intensive treatment target (systolic blood pressure, <120 mm Hg) or a standard treatment target (systolic blood pressure, <140 mm Hg). The primary outcome was a composite of myocardial infarction, other acute coronary syndromes, stroke, acute decompensated heart failure, or death from cardiovascular causes. Additional primary outcome events occurring through the end of the intervention period (August 20, 2015) were adjudicated after data lock for the primary analysis. We also analyzed post-trial observational follow-up data through July 29, 2016. RESULTS: At a median of 3.33 years of follow-up, the rate of the primary outcome and all-cause mortality during the trial were significantly lower in the intensive-treatment group than in the standard-treatment group (rate of the primary outcome, 1.77% per year vs. 2.40% per year; hazard ratio, 0.73; 95% confidence interval [CI], 0.63 to 0.86; all-cause mortality, 1.06% per year vs. 1.41% per year; hazard ratio, 0.75; 95% CI, 0.61 to 0.92). Serious adverse events of hypotension, electrolyte abnormalities, acute kidney injury or failure, and syncope were significantly more frequent in the intensive-treatment group. When trial and post-trial follow-up data were combined (3.88 years in total), similar patterns were found for treatment benefit and adverse events; however, rates of heart failure no longer differed between the groups. CONCLUSIONS: Among patients who were at increased cardiovascular risk, targeting a systolic blood pressure of less than 120 mm Hg resulted in lower rates of major adverse cardiovascular events and lower all-cause mortality than targeting a systolic blood pressure of less than 140 mm Hg, both during receipt of the randomly assigned therapy and after the trial. Rates of some adverse events were higher in the intensive-treatment group. (Funded by the National Institutes of Health; SPRINT ClinicalTrials.gov number, NCT01206062.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“From the first landmark 1967 Veterans Administration Cooperative Study2 to the 2021 SPRINT trial3, all outcome trials in hypertension have used the average of snapshot BP levels to demonstrate the efficacy of antihypertensive drug therapy in reducing cardiovascular events.”
From Blood pressure and its variability: classic and novel measurement techniques (2022) · cites this paper as [3]
Citations
Cites
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Self-citationCox’s regression model for counting processes: A large sample study
Andersen, P. K., & Gill, R. D. (1982) · The Annals of Statistics · doi:10.1214/aos/1176345976 · Cited by 4,419
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S., Prosek, J., Nadasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,376
Effects of intensive blood-pressure control in type 2 diabetes mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001286 · Cited by 3,598
Self-citationThe J-Curve Phenomenon in Hypertension
Kang, Y.-Y., & Wang, J.-G. (2016) · Pulse · doi:10.1159/000446922 · Cited by 1,530
A stagewise rejective multiple test procedure based on a modified Bonferroni test
HOMMEL, G. (1988) · Biometrika · doi:10.1093/biomet/75.2.383 · Cited by 1,367
Intensive Blood-Pressure Control in Hypertensive Chronic Kidney Disease
Appel, L. J., Wright, J. T., Greene, T., Agodoa, L. Y., Astor, B. C., Bakris, G. L., Cleveland, W. H., Charleston, J., Contreras, G., Faulkner, M. L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0910975 · Cited by 719
Ambrosius, W. T., Sink, K. M., Foy, C. G., Berlowitz, D. R., Cheung, A. K., Cushman, W. C., Fine, L. J., Goff, D. C., Johnson, K. C., Killeen, A. A., et al. (2014) · Clinical Trials · doi:10.1177/1740774514537404 · Cited by 544
Holtkamp, F. A., de Zeeuw, D., Thomas, M. C., Cooper, M. E., de Graeff, P. A., Hillege, H. J. L., Parving, H.-H., Brenner, B. M., Shahinfar, S., & Lambers Heerspink, H. J. (2011) · Kidney International · doi:10.1038/ki.2011.79 · Cited by 364
Cited by
Items 401–462 of 462
Wang, C., Tang, H., Yang, Q., Lu, Y., Lin, Z., & Zhang, Y. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05373-1
Epidemiology of metatarsal fractures in Shropshire 2020–2023
Garton, M. J., Rowlands, J., & Roach, R. (2025) · Archives of Osteoporosis · doi:10.1007/s11657-025-01603-7
Verdecchia, P., Angeli, F., & Reboldi, G. (2025) · Hypertension · doi:10.1161/hypertensionaha.125.25902
Diastolic blood pressure as a predictor of short-term mortality in infective endocarditis
Du, S.-L., Li, J., Chen, Y., Wei, X., Chen, Y.-L., Yu, D.-Q., & Wang, Q. (2025) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2025.200522
Xu, X., Zhao, X., Ding, Y., Wu, X., Cao, Q., Wang, K., Yu, X. Y., Wang, S., Zhang, X., Xu, M., et al. (2025) · Journal of Diabetes · doi:10.1111/1753-0407.70162
Won, K., Choi, S.-Y., Chun, E. J., Park, S. H., Sung, J., Jung, H. O., & Chang, H. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-103993
Lee, S., Kim, S. E., Jang, H., Kim, J. P., Sohn, G., Park, Y. H., Ham, H., Gu, Y., Park, C. J., Kim, H. J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26732656
Xie, J., Huang, Y., Zheng, X.-F., Feng, R., Li, X.-Y., Zheng, Z., Jiang, B., Du, S., Chen, H.-G., & Xu, Y. (2024) · Figshare · doi:10.6084/m9.figshare.25001671
Li, C., Chen, K., Shi, G., Shi, R., Wu, Z., Yuan, X., Watson, V., Jiang, Z., Mai, H., Yang, T., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20099677
Ferrari, E. H., Minetto, J., & Ferrari, E. H. (2024) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata)
Nolasco, E. (2025) · Lincoln (University of Nebraska)
Tian, X., Wu, S., Xia, X., Xu, Q., Chen, S., Wang, A., & Fang, R. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70472
Liao, W., Wang, M., Li, L., Dong, W., Liao, J., Liang, W., Jiang, M., Kl, H., & Li, H. (2026) · Research Square · doi:10.21203/rs.3.rs-8548831/v1
Eschenhagen, T., & Weil, J. (2026) · Springer eBooks · doi:10.1007/978-3-662-72738-6_6
Time to benefit estimation in multicenter studies using flexible hazard shared frailty models
Lu, M., Wu, Z., Zhao, Y., & Shao, F. (2026) · BMC Medical Research Methodology · doi:10.1186/s12874-026-02816-1
Cardiovascular complications in arterial hypertension: Prevention strategies and literature review
Vega, A. V. H., Giraldo, L. C. B., Caballero, L. V. P., Sánchez, M. F. C., Álvarez, R. A. N., & Charry, J. D. (2026) · International Journal of Science and Research Archive · doi:10.30574/ijsra.2026.18.3.0476
Rodríguez-Marín, D., Cruz, J., Caballero, F. F., Graciani, A., Rodríguez‐Artalejo, F., & Banegas, J. R. (2026) · Revista Española de Cardiología · doi:10.1016/j.recesp.2026.03.004
Rodrigues, C. I. S., Moura, A. F., & Bezerra, R. (2026) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2025-0335pt
Gallwitz, B., Aberle, J., Birkenfeld, A. L., Kellerer, M., Klein, H. H., Landgraf, R., Müller‐Wieland, D., Müssig, K., Nauck, M. A., Siegel, E. G., et al. (2026) · Die Diabetologie · doi:10.1007/s11428-026-01469-4
Rodrigues, C. I. S., Moura, A. F., & Bezerra, R. (2026) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2025-0335en
Therapieprinzipien und Langzeitbetreuung bei Glomerulonephritiden
Lovric, S., & Walter, S. (2026) · Die Innere Medizin · doi:10.1007/s00108-026-02107-3
Blood Pressure Control and Mortality Among US Veterans
Yamada, M., Griffin, B. R., Shi, Q., Sambharia, M., Swee, M. L., Good, M. K., Kennelty, K. A., Faro, E. Z., Reisinger, H. S., Girotra, S. R., et al. (2026) · Hypertension · doi:10.1161/hypertensionaha.125.25787
Li, M., Shi, J., Chen, M., He, Q., Wang, B., Zhao, S., Li, Y., Zhao, Y., & Zhang, Y. (2026) · Pulse · doi:10.1159/000551995
Chen, S., Ji, Y., Yang, R., Peng, X., Bai, J., Fan, X., Song, Q., & Cai, J. (2026) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2026.04.005
Living Kidney Donation and Hypertension
Garg, N., & Mandelbrot, D. A. (2026) · Transplantation · doi:10.1097/tp.0000000000005735
Hartsell, S. E., Drakos, S. G., Boucher, R. E., Sarwal, A., Fang, J. C., Wei, G., Takyi, A., Bissada, G., Shen, J., & Beddhu, S. (2026) · Kidney Medicine · doi:10.1016/j.xkme.2026.101390
Rodríguez-Marín, D., Cruz, J., Caballero, F. F., Graciani, A., Rodríguez‐Artalejo, F., & Banegas, J. R. (2026) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2026.03.011
Maimaitiwusiman, Z., Xuekelati, S., Wumaier, A., Bai, X., Ma, L. H., Li, Y., Aerken, A., Yang, Y., & Wang, H. B. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-102957
Zhang, Y., Du, J., You, X., Sun, T., Lv, H., Jiang, Y., Jiang, T., Qin, R., Xu, X., Dou, Y., et al. (2026) · BMC Medicine · doi:10.1186/s12916-026-04958-x
Wang, Z., Hu, M., Li, X., Zhang, Z., & Muwei, L. I. (2026) · Research Square · doi:10.21203/rs.3.rs-9358054/v1
Zhu, Y., Nie, Z., Zhou, D., Yan, M., Wang, J., Cai, A., Huang, Y. Q., Luo, S., Ou, Y., & Feng, Y. (2026) · Journal of Clinical Hypertension · doi:10.1111/jch.70275 · Cited by 1
Zoysa, P. D., Weerarathna, T., Darshana, I., Egodage, U., Rathnayake, R., Jayasekara, M. M. P. T., Sujanitha, V., Matthias, A., Ratnayake, B., Mayurathan, P., et al. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-06062-7
Han, J., Zhao, T., Shi, Y., Zhao, Z. C., Wang, W., Ye, Y. C., Bai, Y., Lin, Z., Meng, X., Guo, L., et al. (2026) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm46901
Gallo, G., & Volpe, M. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag421
Ciobanu, A. O., Vittos, O., Dolofan, B., Trambitas, N., Tănăsescu, R., Guja, C., & Vinereanu, D. (2026) · Atherosclerosis Plus · doi:10.1016/j.athplu.2026.100573
He, B.-B., & Wu, G.-Y. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-06162-4
Hypertension Control in Low-Income Patients
Yang, Q., Nazarzadeh, M., & Rahimi, K. (2026) · New England Journal of Medicine · doi:10.1056/nejmc2606180
Xu, H., Guo, Y., Wen, H., Sun, Y., Li, H., & Chen, J. (2026) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x261468909
Jang, M., Park, S., Ann, S. H., Kim, Y., Jeon, Y., Lim, S., Kwon, W.-J., Choi, S. H., Park, H. W., & Park, G. (2026) · PLoS ONE · doi:10.1371/journal.pone.0353359
Li, N., Yuan, Q., Yang, Z., & Cheng, W. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1859944
How useful is a casual BP measurement?
Lewis, P. (2026) · Clinical Medicine · doi:10.1016/j.clinme.2026.100626 · Cited by 1
Wang, Y., Li, Y., & Wang, J.-G. (2026) · American Journal of Hypertension · doi:10.1093/ajh/hpag088
Management von erhöhtem Blutdruck und Bluthochdruck: Risikoreduktion im Fokus
Schmieder, R. S., & Schunkert, H. (2026) · Herz · doi:10.1007/s00059-026-05385-7
A high-value, cross-continuum approach to heart failure: A narrative review
Potharazu, A. V., Mansour, A. I., Berkowitz, S., Bhatla, A., Feeser, S. A., Hill, P., Issa, J., Johnson, P., Segall, H., & Gilotra, N. A. (2026) · The American Journal of Medicine · doi:10.1016/j.amjmed.2026.07.003
Chaves, P. H. M., Desoria, M., Roque, L., & Mas, R. J. (2026) · Journal of Clinical Hypertension · doi:10.1111/jch.70297
Aldosterone in Hypertension: From Secondary Cause to Central Driver
Schiffrin, E. L., Hundemer, G. L., & Goupil, R. (2026) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2026.08.004
Primary Care Hypertension Guidelines: What’s New for Primary Care
Hundemer, G. L., Terenzi, K. A., & Goupil, R. (2026) · Canadian Primary Care Today · doi:10.58931/cpct.2026.4155
Hypertension Control Programs: A Global Call to Action
Post, W. S. (2026) · Circulation · doi:10.1161/circulationaha.126.083073
(2025) · repository of the Library and Information Centre, Hungarian Academy of Sciences (REAL-J)
The 2025 AHA/ACC Hypertension Guidelines: Key Updates, Historical Context, and Clinical Implications
Giacona, J. M., & Vongpatanasin, W. (2026) · Current Cardiology Reports · doi:10.1007/s11886-026-02413-0
Holt, R. I. G., DeVries, J. H., Fischl, A. H., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, É., et al. (2026) · Diabetologia · doi:10.1007/s00125-026-06833-z · Cited by 1
Tiwari, A., Chen, R., Tan, Y., Yan, Y., Wen, Z., Wei, W., Zhong, X. Y., & Li, B. (2026) · medRxiv · doi:10.64898/2026.09.11.26362859
Sriwalosakul, T., Vongsanim, S., Pongsuwan, K., Kusirisin, P., Nochaiwong, S., Ruengorn, C., & Noppakun, K. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2735092
The role of the immune system in hypertension
Fields, E., Berillo, O., & Schiffrin, E. L. (2026) · Journal of Hypertension · doi:10.1097/hjh.0000000000004440
Sarker, S., Banerjee, S., Herazo, C. A. B., Nawab, J., Afra, M., Rayudu, U. S., Abdelkhalik, A. M. H., Patel, R., Bucataru, L., Khizer, U., et al. (2026) · JRSM Cardiovascular Disease · doi:10.1177/20480040261492364
Iatridi, F., Roddick, A., Staplin, N., Che, Z., Liu, J., Arimoto, R., Al-Mohammad, A., Li, Y., Ge, J., Ku, E., et al. (2026) · JAMA Cardiology · doi:10.1001/jamacardio.2026.4445
Blood pressure control in the Kidney Research Network before and after the 2017 guideline change
Weaver, D. J., Putnam, N. M., Adler, S. G., Lafayette, R. A., Robinson, B., Massengill, S. F., Kamil, E. S., Brakeman, P., & Modi, Z. J. (2026) · Glomerular Diseases · doi:10.1159/gdz/acyag006
Debating targets for systolic blood pressure lowering in chronic kidney disease
Dounousi, E. C., Georgianos, P. I., & Agarwal, R. (2026) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfag233
Therapie des Typ-2-Diabetes – Praxisempfehlung der DDG
Gallwitz, B., Aberle, J., Birkenfeld, A. L., Kellerer, M., Klein, H. H., Landgraf, R., Müller‐Wieland, D., Müssig, K., Nauck, M., Siegel, E. G., et al. (2026) · Diabetologie und Stoffwechsel · doi:10.1055/a-2866-0999
Blood pressure targets in adults with hypertension
Larvie, D. Y., Thompson, W., Grenet, G., Wright, J., Jauca, C. D., Salzwedel, D. M., Adams, S., & Ambasta, A. (2026) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd016397
Prota, D. C. G. (2026) · Evidencia actualizacion en la práctica ambulatoria · doi:10.51987/evidencia.v29i4.7236
Metadata
- Authors
- The SPRINT Research Group
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- The SPRINT Research Group
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2021-05-20
- Volume
- 384
- Issue
- 20
- Pages
- 1921-1930
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC9907774
- OpenAlex
- W3161638097
- Cited by
- 454
- References
- 20
- Citations by year
- 2026: 74 · 2025: 92 · 2024: 74 · 2023: 83 · 2022: 105 · 2021: 26
- FWCI
- 48.27
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health, National Heart, Lung, and Blood Institute
- National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
- NIH, National Institute on Aging
- NIH, National Institute of Neurological Disorders and Stroke
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- intensive blood pressure control, systolic blood pressure target, antihypertensive therapy, major adverse cardiovascular events, all-cause mortality, cardiovascular risk, adverse events, acute kidney injury, heart failure, post-trial follow-up, SPRINT trial, acute coronary syndrome, stroke, myocardial infarction, syncope, electrolyte imbalance, hypotension
- MeSH terms
- Aged, Antihypertensive Agents, Blood Pressure, Cardiovascular Diseases, Female, Follow-Up Studies, Humans, Hypertension, Male, Middle Aged
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.